Trial intelligence / Profile preview

Tamsulosin for Postoperative Urinary Retention in Spine Surgery

NCT01568918Phase 3Terminated

Sponsor
Mayo Clinic
Start
May 2012
Primary completion
Nov 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in postoperative urinary retention (POUR) comparing Tamsulosin with Placebo (2 arms). Primary endpoint: Incidence of Postoperative Urinary Retention. Started May 2012; status: terminated.

02

Drugs

tamsulosin
03

Conditions

postoperative urinary retention (POUR)

Beyond the preview

Go deeper on NCT01568918.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01568918.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call